Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

NCT00327171 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Cancer of the Ovary

Interventions

DRUG: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
DRUG: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

Sponsor

Sanofi

Collaborators

[object Object]